0000950123-22-005030.txt : 20220510
0000950123-22-005030.hdr.sgml : 20220510
20220510162523
ACCESSION NUMBER: 0000950123-22-005030
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20220331
FILED AS OF DATE: 20220510
DATE AS OF CHANGE: 20220510
EFFECTIVENESS DATE: 20220510
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Versant Venture Management, LLC
CENTRAL INDEX KEY: 0001560009
IRS NUMBER: 954767945
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-16849
FILM NUMBER: 22910098
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-233-7877
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
13F-HR
1
primary_doc.xml
13F-HR
LIVE
0001560009
XXXXXXXX
03-31-2022
03-31-2022
false
Versant Venture Management, LLC
One Sansome Street, Suite 3630
San Francisco
CA
94104
13F HOLDINGS REPORT
028-16849
N
Robin L. Praeger
Managing Director
(415) 801-8100
/s/ Robin L. Praeger
San Francisco
CA
05-10-2022
0
10
100171
false
INFORMATION TABLE
2
13154.xml
INFORMATION TABLE FOR FORM 13F
Adverum Biotechnologies, Inc.
Common Stock
00773U108
6639
5068233
SH
OTR
0
5068233
0
Akero Therapeutics, Inc.
Common Stock
00973Y108
8766
617727
SH
OTR
0
617727
0
Aligos Therapeutics, Inc.
Common Stock
01626L105
4989
2320381
SH
OTR
0
2320381
0
Clovis Oncology, Inc.
Common Stock
189464100
206
101855
SH
OTR
0
101855
0
Crinetics Pharmaceuticals, Inc.
Common Stock
22663K107
9007
410360
SH
OTR
0
410360
0
CRISPR Therapeutics AG
Common Shares
H17182108
31294
498558
SH
OTR
0
498558
0
CymaBay Therapeutics, Inc.
Common Stock
23257D103
1691
543753
SH
OTR
0
543753
0
Gritstone Oncology, Inc.
Common Stock
39868T105
14672
3561150
SH
OTR
0
3561150
0
Minerva Surgical Inc.
Common Stock
60343F106
7532
1673700
SH
OTR
0
1673700
0
Passage Bio, Inc.
Common Stock
702712100
15375
4959769
SH
OTR
0
4959769
0